β-Arrestin 2 is required for the induction and strengthening of integrin-mediated leukocyte adhesion during CXCR2-driven extravasation

Blood

Volumn 114, Issue 5, 2009, Pages 1073-1082

  Molteni, Raffaella ^a,b   Crespo, Carolina Lage ^a,b   Feigelson, Sara ^c   Moser, Christian ^d   Fabbri, Monica ^a,b   Grabovsky, Valentin ^c   Krombach, Fritz ^d   Laudanna, Carlo ^e   Alon, Ronen ^c   Pardi, Ruggero ^a,b  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^e UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ARRESTIN 1; BETA ARRESTIN 2; BETA1 INTEGRIN; BETA2 INTEGRIN; CHEMOKINE RECEPTOR CXCR2; GUANOSINE TRIPHOSPHATASE; INTEGRIN; KERATINOCYTE DERIVED CHEMOKINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C; RAP1 PROTEIN; RAP1A PROTEIN; RAP1B PROTEIN; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN 4; BETA ARRESTIN; COMPLEMENTARY DNA; HYBRID PROTEIN; RETINA S ANTIGEN; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL INTERACTION; CONTROLLED STUDY; ENZYME ACTIVATION; EXTRAVASATION; LEUKOCYTE ADHERENCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SHEAR STRESS; ANIMAL; BONE MARROW CELL; CYTOLOGY; DRUG EFFECT; GENETICS; KERATINOCYTE; LEUKOCYTE; LEUKOCYTE ROLLING; MALE; MAST CELL LEUKEMIA; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; SHEAR STRENGTH; TUMOR CELL LINE; VENULE;

ANIMALS; ARRESTINS; CELL ADHESION; CELL LINE, TUMOR; DNA, COMPLEMENTARY; INTEGRIN ALPHA4BETA1; KERATINOCYTES; LEUKEMIA, BASOPHILIC, ACUTE; LEUKOCYTE ROLLING; LEUKOCYTES; MALE; MICE; MICE, KNOCKOUT; MYELOID CELLS; RATS; RECEPTORS, INTERLEUKIN-8B; RECOMBINANT FUSION PROTEINS; RNA, SMALL INTERFERING; SHEAR STRENGTH; VASCULAR CELL ADHESION MOLECULE-1; VENULES;

EID: 70349257809     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-10-183699     Document Type: Article

References (50)

1. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 1994;76:301-314.
2. Molteni R, Fabbri M, Bender JR, Pardi R. Pathophysiology of leukocyte-tissue interactions. Curr Opin Cell Biol. 2006;18:491-498.
3. Ley K, Laudanna C, Cybulsky MI, Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol. 2007;7:678-689. (Pubitemid 47327397)
4. McEver RP. Selectins: lectins that initiate cell adhesion under flow. Curr Opin Cell Biol. 2002;14: 581-586.
5. Constantin G, Majeed M, Giagulli C, et al. Chemokines trigger immediate β2 integrin affinity and mobility changes: differential regulation and roles in lymphocyte arrest under flow. Immunity. 2000; 13:759-769. (Pubitemid 32041799)
6. Grabovsky V, Feigelson S, Chen C, et al. Subsecond induction of α4 integrin clustering by immobilized chemokines stimulates leukocyte tethering and rolling on endothelial vascular cell adhesion molecule 1 under flow conditions. J Exp Med. 2000;192:495-506. (Pubitemid 30666250)
7. Laudanna C, Kim JY, Constantin G, Butcher E. Rapid leukocyte integrin activation by chemokines. Immunol Rev. 2002;186:37-46.
8. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell. 2002;110:673-687.
9. Kinashi T. Intracellular signalling controlling integrin activation in lymphocytes. Nat Rev Immunol. 2005;5:546-559. (Pubitemid 40961332)
10. Lipowsky HH. Shear stress in the circulation. In: Bevan JA, Kaley G, Rubanyi GM, eds. Flow Dependent Regulation of Vascular Function. New York, NY: Oxford University Press; 1995:28-45.
11. Alon R, Ley K. Cells on the run: shear-regulated integrin activation in leukocyte rolling and arrest on endothelial cells. Curr Opin Cell Biol. 2008;20: 525-532.
12. Luttrell LM, Lefkowitz RJ. The role of β-arrestins in the termination and transduction of G-proteincoupled receptor signals. J Cell Sci. 2002;115: 455-465.
13. DeWire SM, Ahn S, Lefkowitz RJ, Shenoy SK. β-arrestins and cell signaling. Annu Rev Physiol. 2007;69:483-510.
14. Bhattacharya M, Anborgh PH, Babwah AV, et al. β-arrestins regulate a Ral-GDS Ral effector pathway that mediates cytoskeletal reorganization. Nat Cell Biol. 2002;4:547-555. (Pubitemid 34905593)
15. Luttrell LM, Ferguson SS, Daaka Y, et al. β-arrestin- dependent formation of β2 adrenergic receptor- Src protein kinase complexes. Science. 1999; 283:655-661. (Pubitemid 129506227)
16. Povsic TJ, Kohout TA, Lefkowitz RJ. β-arrestin1 mediates insulin-like growth factor 1 (IGF-1) activation of phosphatidylinositol 3-kinase (PI3K) and anti-apoptosis. J Biol Chem. 2003;278:51334-51339.
17. Barnes WG, Reiter E, Violin JD, Ren XR, Milligan G, Lefkowitz RJ. β-Arrestin 1 and Gαq/11 coordinately activate RhoA and stress fiber formation following receptor stimulation. J Biol Chem. 2005; 280:8041-8050. (Pubitemid 40349702)
18. DeFea KA, Zalevsky J, Thoma MS, Dery O, Mullins RD, Bunnett NW. β-Arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2. J Cell Biol. 2000;148:1267-1281. (Pubitemid 30688135)
19. Ge L, Ly Y, Hollenberg M, DeFea K. A β-arrestin-dependent scaffold is associated with prolonged MAPK activation in pseudopodia during protease-activated receptor-2-induced chemotaxis. J Biol Chem. 2003;278:34418-34426. (Pubitemid 37553288)
20. McDonald PH, Chow CW, Miller WE, et al. β-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3. Science. 2000;290:1574-1577.
21. Sun Y, Cheng Z, Ma L, Pei G. β-arrestin2 is critically involved in CXCR4-mediated chemotaxis, and this is mediated by its enhancement of p38 MAPK activation. J Biol Chem. 2002;277:49212-49219. (Pubitemid 36014350)
22. Gavard J, Gutkind JS. VEGF controls endothelial-cell permeability by promoting the β-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol. 2006;8:1223-1234. (Pubitemid 44660587)
23. DeFea KA. Stop that cell! β-arrestin-dependent chemotaxis: a tale of localized actin assembly and receptor desensitization. Annu Rev Physiol. 2007;69:535-560.
24. Mempel TR, Moser C, Hutter J, Kuebler WM, Krombach F. Visualization of leukocyte transendothelial and interstitial migration using reflected light oblique transillumination in intravital video microscopy. J Vasc Res. 2003;40:435-441. (Pubitemid 37465091)
25. Wegmann F, Petri B, Khandoga AG, et al. ESAM supports neutrophil extravasation, activation of Rho, and VEGF-induced vascular permeability. J Exp Med. 2006;203:1671-1677. (Pubitemid 44036272)
26. Valtieri M, Tweardy DJ, Caracciolo D, et al. Cytokine- dependent granulocytic differentiation. Regulation of proliferative and differentiative responses in a murine progenitor cell line. J Immunol. 1987;138:3829-3835. (Pubitemid 17078259)
27. Feigelson SW, Grabovsky V, Winter E, et al. The Src kinase p56(lck) up-regulates VLA-4 integrin affinity. Implications for rapid spontaneous and chemokine-triggered T cell adhesion to VCAM-1 and fibronectin. J Biol Chem. 2001;276:13891-13901. (Pubitemid 37391769)
28. Pasvolsky R, Feigelson SW, Kilic SS, et al. A LAD-III syndrome is associated with defective expression of the Rap-1 activator CalDAG-GEFI in lymphocytes, neutrophils, and platelets. J Exp Med. 2007;204:1571-1582. (Pubitemid 47048024)
29. Bolomini-Vittori M, Montresor A, Giagulli C, et al. Regulation of conformer-specific activation of the integrin LFA-1 by a chemokine-triggered Rho signaling module. Nat Immunol. 2009;10:185-194.
30. + indicators with greatly improved fluorescence properties. J Biol Chem. 1985;260: 3440-3450.
31. Walker JK, Fong AM, Lawson BL, et al. β-arrestin- 2 regulates the development of allergic asthma. J Clin Invest. 2003;112:566-574. (Pubitemid 38056341)
32. Fong AM, Premont RT, Richardson RM, Yu YR, Lefkowitz RJ, Patel DD. Defective lymphocyte chemotaxis in β-arrestin2- and GRK6-deficient mice. Proc Natl Acad Sci U S A. 2002;99:7478-7483.
33. Yasuda M, Hasunuma Y, Adachi H, et al. Expression and function of fibronectin binding integrins on rat mast cells. Int Immunol. 1995;7:251-258.
34. DiVietro JA, Brown DC, Sklar LA, Larson RS, Lawrence MB. Immobilized stromal cell-derived factor-1α triggers rapid VLA-4 affinity increases to stabilize lymphocyte tethers on VCAM-1 and subsequently initiate firm adhesion. J Immunol. 2007; 178:3903-3911.
35. Berlin C, Bargatze RF, Campbell JJ, et al. α 4 Integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell. 1995;80:413-422.
36. Shimonaka M, Katagiri K, Nakayama T, et al. Rap1 translates chemokine signals to integrin activation, cell polarization, and motility across vascular endothelium under flow. J Cell Biol. 2003;161:417-427. (Pubitemid 36529858)
37. Bos JL. Linking Rap to cell adhesion. Curr Opin Cell Biol. 2005;17:123-128.
38. Ahn S, Wei H, Garrison TR, Lefkowitz RJ. Reciprocal regulation of angiotensin receptor-activated extracellular signal-regulated kinases by β-arrestins 1 and 2. J Biol Chem. 2004;279:7807-7811. (Pubitemid 38294665)
39. Pizon V, Lerosey I, Chardin P, Tavitian A. Nucleotide sequence of a human cDNA encoding a rasrelated protein (rap1B). Nucleic Acids Res. 1988; 16:7719. (Pubitemid 18194777)
40. Su Y, Raghuwanshi SK, Yu Y, Nanney LB, Richardson RM, Richmond A. Altered CXCR2 signaling in β-arrestin-2-deficient mouse models. J Immunol. 2005;175:5396-5402. (Pubitemid 41456426)
41. Violin JD, Lefkowitz RJ. β-arrestin-biased ligands at seven-transmembrane receptors. Trends Pharmacol Sci. 2007;28:416-422.
42. Alon R, Dustin ML. Force as a facilitator of integrin conformational changes during leukocyte arrest on blood vessels and antigen-presenting cells. Immunity. 2007;26:17-27. (Pubitemid 46109349)
43. Giagulli C, Scarpini E, Ottoboni L, et al. RhoA and zeta PKC control distinct modalities of LFA-1 activation by chemokines: critical role of LFA-1 affinity triggering in lymphocyte in vivo homing. Immunity. 2004;20:25-35. (Pubitemid 38134291)
44. Kim GH, Han JK. Essential role for β-arrestin 2 in the regulation of Xenopus convergent extension movements. EMBO J. 2007;26:2513-2526.
45. Shenoy SK, Drake MT, Nelson CD, et al. β-Arrestin- dependent, G protein-independent ERK1/2 activation by the β2 adrenergic receptor. J Biol Chem. 2006;281:1261-1273.
46. Kinashi T, Aker M, Sokolovsky-Eisenberg M, et al. LAD-III, a leukocyte adhesion deficiency syndrome associated with defective Rap1 activation and impaired stabilization of integrin bonds. Blood. 2004;103:1033-1036. (Pubitemid 38129568)
47. Sebzda E, Bracke M, Tugal T, Hogg N, Cantrell DA. Rap1A positively regulates T cells via integrin activation rather than inhibiting lymphocyte signaling. Nat Immunol. 2002;3:251-258. (Pubitemid 34213426)
48. Katagiri K, Shimonaka M, Kinashi T. Rap1-mediated lymphocyte function-associated antigen-1 activation by the T cell antigen receptor is dependent on phospholipase C- γ1. J Biol Chem. 2004; 279:11875-11881. (Pubitemid 38401692)
49. Bergmeier W, Goerge T, Wang HW, et al. Mice lacking the signaling molecule CalDAG-GEFI represent a model for leukocyte adhesion deficiency type III. J Clin Invest. 2007;117:1699-1707. (Pubitemid 46871354)
50. Ghandour H, Cullere X, Alvarez A, Luscinskas FW, Mayadas TN. Essential role for Rap1 GT-Pase and its guanine exchange factor CalDAGGEFI in LFA-1 but not VLA-4 integrin mediated human T-cell adhesion. Blood. 2007;110:3682-3690. (Pubitemid 350159637)